Deterioration of glomerular endothelial surface layer and the alteration in the renal function after a growth promoter boldenone injection in rabbits

Human and Experimental Toxicology

Volumn 31, Issue 5, 2012, Pages 465-472

  Alm Eldeen, A ^a   Tousson, E ^a  

^a Tanta University   (Egypt)

Author keywords

boldenone; histopathology; kidney; rabbits; toxicology

Indexed keywords

ALBUMIN; BOLDENONE; CREATININE; EQUIGAN; GANABOL; GLOBULIN; OLIVE OIL; STEROID; ULTRAGAN; UNCLASSIFIED DRUG; UREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; GLOMERULOSCLEROSIS; GLOMERULUS; HISTOPATHOLOGY; KIDNEY FUNCTION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RABBIT; SCORING SYSTEM; SPORT; UREA BLOOD LEVEL; VETERINARY MEDICINE;

ANIMALS; ANTIGENS, CD34; CREATININE; ENDOTHELIAL CELLS; GROWTH SUBSTANCES; INJECTIONS, INTRAMUSCULAR; KIDNEY GLOMERULUS; MALE; RABBITS; SERUM ALBUMIN; SERUM GLOBULINS; TESTOSTERONE; UREA;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 84864225568     PISSN: 09603271     EISSN: 14770903     Source Type: Journal    
DOI: 10.1177/0960327111420745     Document Type: Article

References (43)

1. Schänzer W. Metabolism of anabolic androgenic steroids. Clin Chem. 1996 ; 42: 1001-1020 (Pubitemid 26231406)
2. Yesalis CE, Bahrke MS, Kopstein AN, Kennedy NJ Anabolic steroids in sport and exercise. 2 nd ed. Champaign, 2000, pp.73-115. Yesalis CE, ed. 2000: 73-115.
3. Kicman AT. Pharmacology of anabolic steroids. Br J Pharmacol. 2008 ; 154: 502-521 (Pubitemid 351744954)
4. Guan F, Cornelius EU, Soma R, Youwen Y, Liu Y, Lia X. High-throughput UHPLC MS/MS method for the detection, quantification and identification of fifty-five anabolic and androgenic steroids in equine plasma. J Mass Spectrom. 2010 ;:
5. Sundlof SF. Veterinary pharmacology therapeutics. 8 th ed. Ames, IA: IowaState UniversityPress, 2001, p.1155. Adams HR, ed. Ames, IA: Iowa State University Press ; 2001: 1155.
6. Soma LR, Uboh CE, Guan F, MC-Donnell S, Pack J. Pharmacokinetics of boldenone and stanozolol and the results of quantification of anabolic and androgenic steroids in race horses and nonrace horses. J Vet Pharmacol Therap. 2007 ; 30: 101-108 (Pubitemid 46365033)
7. Yesalis CE, Kennedy NJ, Kopstein AN, Bahrke MS. Anabolic-androgenic steroid use in the United States. JAMA. 1993 ; 270: 1217-1221 (Pubitemid 23262352)
8. Sullivan ML, Martinez CM, Gennis P, Gallagher EJ. The cardiac toxicity of anabolic steroids. Prog Cardiovasc Dis. 1998 ; 41: 1-15 (Pubitemid 28385246)
9. Kuhn CM. Anabolic steroids. Recent Prog Horm Res. 2002 ; 57: 411-434
10. De Brabander HF, Poelmans S, Schilt R, et al. Presence and metabolism of the anabolic steroid boldenone in various animal species: a review. Food Addit Contam. 2004 ; 21: 515-525 (Pubitemid 38885963)
11. Mooradian AD, Morley JE, Korenman SG. Biological actions of androgens. Endocr Rev. 1987 ; 8: 1-28
12. Hoffmann U. Anabolic steroids-a problem in popular sports. T + K. 2002 ; 69: 136
13. BrookhouseB.Two More Positive Drug Tests. In Fight World. bloodyelbow.com. http://www.bloodyelbow.com/story/2007/8/17/02615/9740
14. Gabr F, Abo El-Maaty T, Amal M, Aotifa AM. Effects of growth promoter boldenone undecylenate on weaned male lambs. Nat Sci. 2009 ; 7: 61-69
15. Kang DH, Kanellis J, Hugo C, et al. Role of the microvascular endothelium in progressive renal disease. J Am Soc Nephrol. 2002 ; 13: 806-816 (Pubitemid 34183950)
16. Bohle A, von Gise H, Mackensen-Haen S, Stark-Jakob B.. The obliteration of the postglomerular capillaries and its influence upon the function of both glomeruli and tubuli. Functional interpretation of morphologic findings. Klin Wochenschr. 1981 ; 59: 1043-1051 (Pubitemid 11059685)
17. Kelly DJ, Hepper C, Wu L, Cox AJ, Gilbert RE. Vascular endothelial growth factor expression and glomerular endothelial cell loss in the remnant kidney model. Nephrol Dial Transplant. 2003 ; 18: 1286-1292 (Pubitemid 36826947)
18. Haraldsson B, Nystrom J, Deen WM. Properties of the glomerular barrier and mechanisms of proteinuria. Physiol Rev. 2008 ; 88: 451-487 (Pubitemid 351522745)
19. Kuwabara A, Satoh M, Tomita N, Sasaki T, Kashihara N. Deterioration of glomerular endothelial surface layer induced by oxidative stress is implicated in altered permeability of macromolecules in Zucker fatty rats. Diabetologia. 2010 ; 53: 2056-2065
20. Civin CI, Strauss LC, Brovall C, Fackler MJ, Schwartz JF, Shaper JH.. Antigen analysis of hematopoiesis. III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-1a cells. J Immunol. 1984 ; 133: 157-165 (Pubitemid 14076703)
21. Pusztaszeri MP, Seelentag W, Bossman FT.. Immunohistochemical expression of endothelial markets CD31, CD34, von Willebrand factor, and Fli-1 in normal human tissues. J Histochem Cytochem. 2006 ; 54: 385-395
22. Fina L, Molgaard HV, Robertson D.. Expression of the CD34 gene in vascular endothelial cells. Blood. 1990 ; 75: 2417-2426 (Pubitemid 20202322)
23. Lin G, Finger E, Gutierrez-Ramos JC. Expression of CD34 in endothelial cells, hematopoietic progenitors and nervous cells in fetal and adult mouse tissues. Eur J Immunol. 1995 ; 25: 1508-1516
24. Acevedo LM, Londono I, Oubaha M, Ghitescu L, Bendayan M. Glomerular CD34 expression in short- and long-term diabetes. J Histochem Cytochem. 2008 ; 54: 385-395
25. Bahrke MS, Yesalis CE, Kopstein AN, Stepkens JA. Risk factors associated with anabolic-androgenic steroid use among adolescents. Sports Med. 2000 ; 29: 397-405 (Pubitemid 30392020)
26. Hughes TK, Fulep E, Juelich T, Smith EM, Stanton GJ. Modulation of immune responses by anabolic androgenic steroids. Int J Immunopharmacol. 1995 ; 17: 857-863
27. Bancroft JD, Cook HC Manual of histological techniques and their diagnostic application. Edinburgh: Churchill Livingstone ; 1994: 23-26.
28. Sternberger LA. Immunocytochemistry. 2 nd ed. New York: John Wiley and sons, 1979, pp.104-169. Cohen S and McClusky RT, ed. New York: John Wiley and sons ; 1979: 104-169.
29. Namikoshi T, Tomita N, Fujimoto S. Isohumulones derived from hops ameliorate renal injury via an anti-oxi effect in Dahl salt-sensitive rats. Hypertens Res. 2007 ; 30: 175-184 (Pubitemid 46541792)
30. van den Berg BM, Vink H, Spaan JA. The endothelial glycocalyx protects against myocardial edema. Circ Res. 2003 ; 92: 592-594 (Pubitemid 36417691)
31. Singh A, Satchell SC, Neal CR, McKenzie EA, Tooke JE, Mathieson PW. Glomerular endothelial glycocalyx constitutes a barrier to protein permeability. J Am Soc Nephrol. 2007 ; 18: 2885-2893 (Pubitemid 350058395)
32. Hillege HL, Fidler V, Diercks GF, et al. Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation. 2002 ; 106: 1777-1782
33. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004 ; 351: 1296-1305
34. Gerstein HC, Mann JF, Yi Q, et al. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA. 2001 ; 286: 421-426 (Pubitemid 32681484)
35. Tarbell JM, Pahakis MY. Mechanotransduction and the glycocalyx. J Int Med. 2006 ; 259: 339-350 (Pubitemid 43384225)
36. Allen BL, Filla MS, Rapraeger AC. Role of heparan sulfate as a tissue-specific regulator of FGF-4 and FGF receptor recognition. J Cell Biol. 2001 ; 155: 845-858
37. Wilsie LC, Orlando RA. The low density lipoprotein receptor-related protein complexes with cell surface heparin sulfate proteoglycans to regulate proteoglycan-mediated lipoprotein catabolism. J Biol Chem. 2003 ; 278: 15758-15764 (Pubitemid 36799688)
38. Kato H. Regulation of functions of vascular wall cells by tissue factor pathway inhibitor: basic and clinical aspects. Arterioscler Thromb Vasc Biol. 2002 ; 22: 539-548 (Pubitemid 34408731)
39. Jeansson M, Bjorck K, Tenstad O, Haraldsson B. Adriamycin alters glomerular endothelium to induce proteinuria. J Am Soc Nephrol. 2009 ; 20: 114-122
40. Dickerman RD, Pertusi RM, Zachariah NY, Dufour DR, McConathy WJ. Anabolic steroid induced hepatotoxicity: is it overstated?. Clin J Sport Med. 1999 ; 9: 34-39
41. Welder AA,, Robertson JW, Melchert RB. Toxic effects of anabolic-androgenic steroids in primary rat hepatic cultures. J Pharmacol Toxicol Methods. 1995 ; 33: 187-195
42. Tousson E, Alm-Eldeen E, El-Moghazy M. p53 and Bcl-2 expression in response to boldenone induced liver cells injury. Toxicol Ind Health. 2011 ; 28: 711-718
43. Hartgens F, Kuipers H. Effects of androgenic-anabolic steroids in athletes. Sports Med. 2004 ; 34: 513-554 (Pubitemid 38981844)